|
Investors and Shareholders
MDS Inc. Corporate Profile
MDS Inc. (TSX: MDS; NYSE: MDZ) is a global life sciences company that provides market-leading products and services that are used by its customers for the development of drugs, and the diagnosis and treatment of disease. MDS is a recognized global provider of innovative technologies for use in medical imaging and radiotherapeutics, sterilization, pharmaceutical contract research and analytical instruments.
MDS's three core businesses – MDS Nordion, MDS Pharma Services and MDS Analytical Technologies – are at the forefront of innovation in their respective industry sectors.
MDS Nordion is a global leader in the provision of innovative technologies for use in medical imaging and radiotherapeutics, and sterilization. Based in Ottawa, its products and services benefit the lives of millions of people in more than 50 countries around the world. MDS Nordion products and services are used on a daily basis by pharmaceutical and biotechnology companies, medical-device manufacturers, hospitals, clinics, and research laboratories.
MDS Pharma Services is a global leader committed to delivering Quality On Time™ service. The contract research organization offers a range of resources to meet the drug discovery and development needs of the pharmaceutical and biotechnology industries. With facilities strategically located in key geographies throughout the world, MDS Pharma Services applies advanced scientific and technological expertise throughout the Early Stage drug discovery and development process (Discovery through Phase IIa).
MDS Analytical Technologies is a global leader focused on the research, design, manufacture and marketing of state-of-the-art solutions for mass spectrometry, drug discovery and bioresearch. MDS Analytical Technologies products are designed to help accelerate the complex process of discovering and developing new drug compounds, understanding the causes of disease, and protecting the safety of food, water and the environment.
MDS stock trades on the Toronto Stock Exchange (TSX: MDS) and on the New York Stock Exchange (NYSE: MDZ). MDS is part of the S&P/TSX 60 and the S&P/TSX Capped Health Care Index.
We welcome questions from our investors and shareholders. For general investor information, please call our automated MDS Shareholder Communication Service at 1 888 MDS 7222 in North America . For specific inquiries, we invite you to contact:
Catherine Love,
Manager, Investor Relations,
MDS Inc.
Tel: +1 905 267 4230
Email: catherine.love@mdsinc.com
MDS Inc.
2810 Matheson Blvd. East
Suite 500
Mississauga , Ontario
L4W 4X7
Canada
 Back to Top
|
